World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
44
Citations
6879
World Ranking
4798
National Ranking
2152

Luis M. de la Maza publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Luis M. de la Maza sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 182 publications — 28th percentile

28% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Luis M. de la Maza D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Luis M. de la Maza sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 44 D-Index — 4th percentile

4% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Luis M. de la Maza is affiliated with the University of California, Irvine in the United States and has a research focus primarily situated in immunology, microbiology, and medicine. Their work spans various subfields, including microbiology, epidemiology, immunology, surgery, and ecology. The scientist's main areas of research include reproductive tract infections, cervical cancer and HPV, genital health and disease, immune response and inflammation, bacterial infections and vaccines, hepatitis B virus studies, and urinary tract infections management.

Frequent collaborators in their research include Sukumar Pal, Matthew A. Coleman, Delia F. Tifrea, Sean F. Gilmore, and Amy Rasley. Their research output is published predominantly in specialized journals focusing on vaccines and infectious diseases. The key publication venues frequently featuring their work are:

  • npj Vaccines
  • Vaccines
  • Pathogens
  • PLoS ONE
  • bioRxiv (Cold Spring Harbor Laboratory)

Their recent significant publications highlight various aspects of vaccine development and infectious disease protection strategies. These include:

  • A modular vaccine platform enabled by decoration of bacterial outer membrane vesicles with biotinylated antigens (2023, Nature Communications)
  • Chlamydia trachomatis vaccines for genital infections: where are we and how far is there to go? (2021, Expert Review of Vaccines)
  • Vaccination with the recombinant major outer membrane protein elicits long-term protection in mice against vaginal shedding and infertility following a Chlamydia muridarum genital challenge (2020, npj Vaccines)
  • Improved protection against Chlamydia muridarum using the native major outer membrane protein trapped in Resiquimod-carrying amphipols and effects in protection with addition of a Th1 (CpG-1826) and a Th2 (Montanide ISA 720) adjuvant (2020, Vaccine)
  • Protection against a chlamydial respiratory challenge by a chimeric vaccine formulated with the Chlamydia muridarum major outer membrane protein variable domains using the Neisseria lactamica porin B as a scaffold (2020, npj Vaccines)

The scientist's research addresses key challenges in vaccine formulation and efficacy, particularly concerning Chlamydia species and related bacterial infections. Their output reflects a sustained contribution to understanding immune responses and advancing vaccine development.

Best Publications

  • Chlamydia infections and heart disease linked through antigenic mimicry.

    Kurt Bachmaier;Kurt Bachmaier;Nikolaus Neu;Luis M. de la Maza;Sukumar Pal

  • Imaging of Effector Memory T Cells during a Delayed-Type Hypersensitivity Reaction and Suppression by Kv1.3 Channel Block

    Melanie P. Matheu;Christine Beeton;Adriana Garcia;Victor Chi

  • Vaccination with the Chlamydia trachomatis Major Outer Membrane Protein Can Elicit an Immune Response as Protective as That Resulting from Inoculation with Live Bacteria

    Sukumar Pal;Ellena M. Peterson;Luis M. de la Maza

  • The 7.5-kb plasmid present in Chlamydia trachomatis is not essential for the growth of this microorganism.

    Ellena M. Peterson;Brian A. Markoff;Julius Schachter;Luis M. de la Maza

  • Adeno-associated virus autointerference

    Barrie J. Carter;Catherine A. Laughlin;Luis M. de la Maza;Maureen Myers

  • Chlamydia trachomatis Native Major Outer Membrane Protein Induces Partial Protection in Nonhuman Primates: Implication for a Trachoma Transmission-Blocking Vaccine

    Laszlo Kari;William M. Whitmire;Deborah D. Crane;Nathalie Reveneau

  • Update on Chlamydia trachomatis Vaccinology.

    Luis M. de la Maza;Guangming Zhong;Robert C. Brunham

  • Monoclonal immunoglobulin A antibody to the major outer membrane protein of the Chalamydia trachomatis mouse pneumonitis biovar protects mice against a chlamydial genital challenge

    Sukumar Pal;Ida Theodor;Ellena M. Peterson;Luis M. de la Maza

  • Immunization with the Chlamydia trachomatis mouse pneumonitis major outer membrane protein can elicit a protective immune response against a genital challenge.

    Sukumar Pal;I. D. A. Theodor;Ellena M. Peterson;Luis M. De La Maza

  • Vaccination of mice with DNA plasmids coding for the Chlamydia trachomatis major outer membrane protein elicits an immune response but fails to protect against a genital challenge.

    Sukumar Pal;Kerry M Barnhart;Qun Wei;Anna M Abai

  • Protection against infertility in a BALB/c mouse salpingitis model by intranasal immunization with the mouse pneumonitis biovar of Chlamydia trachomatis.

    Sukumar Pal;T. J. Fielder;E. M. Peterson;L. M. De La Maza

  • Targeting the inhibitory receptor CTLA-4 on T cells increased abscopal effects in murine mesothelioma model

    Licun Wu;Matthew Onn Wu;Luis De la Maza;Zhihong Yun

  • A new computer model for estimating the impact of vaccination protocols and its application to the study of Chlamydia trachomatis genital infections.

    Michael A. de la Maza;Luis M. de la Maza

  • Structural and Functional Analyses of the Major Outer Membrane Protein of Chlamydia trachomatis

    Guifeng Sun;Sukumar Pal;Annahita K. Sarcon;Soyoun Kim

  • Vaccines for Chlamydia trachomatis infections.

    Luis M de la Maza;Ellena M Peterson

  • Up-regulation of the JAK/STAT1 signal pathway during Chlamydia trachomatis infection.

    Sonya P. Lad;Elaine Y. Fukuda;Jiali Li;Luis M. de la Maza

  • Temporal expression of type III secretion genes of Chlamydia pneumoniae.

    Anatoly Slepenkin;Vladimir Motin;Luis M. de la Maza;Ellena M. Peterson

  • Reversal of the Antichlamydial Activity of Putative Type III Secretion Inhibitors by Iron

    Anatoly Slepenkin;Per-Anders Enquist;Ulrik Hägglund;Luis M. de la Maza

  • Screening of Urine Cultures by Three Automated Systems

    Marie T. Pezzlo;Grace L. Tan;Ellena M. Peterson;Luis M. De La Maza

  • Functional and structural mapping of Chlamydia trachomatis species-specific major outer membrane protein epitopes by use of neutralizing monoclonal antibodies.

    E. M. Peterson;Xun Cheng;B. A. Markoff;T. J. Fielder

  • Immunization with the Chlamydia trachomatis major outer membrane protein, using adjuvants developed for human vaccines, can induce partial protection in a mouse model against a genital challenge.

    Sukumar Pal;Ellena M. Peterson;Rino Rappuoli;Giulio Ratti

  • Protection against an intranasal challenge by vaccines formulated with native and recombinant preparations of the Chlamydia trachomatis major outer membrane protein

    Guifeng Sun;Sukumar Pal;Joseph Weiland;Ellena M. Peterson

  • Role of endogenous gamma interferon in host defense against Chlamydia trachomatis infections.

    Guangming Zhong;E. M. Peterson;C. W. Czarniecki;R. D. Schreiber

  • Immunization with the Chlamydia trachomatis Mouse Pneumonitis Major Outer Membrane Protein by Use of CpG Oligodeoxynucleotides as an Adjuvant Induces a Protective Immune Response against an Intranasal Chlamydial Challenge

    Sukumar Pal;Heather L. Davis;Ellena M. Peterson;Luis M. de la Maza

  • Factors influencing the induction of infertility in a mouse model of Chlamydia trachomatis ascending genital tract infection

    Sukumar Pal;Wei Hui;Ellena M. Peterson;Luis M. De La Maza

Frequent Co-Authors

Ellena M. Peterson
Ellena M. Peterson University of California, Irvine
Marc de Perrot
Marc de Perrot University of Toronto
Philip L. Felgner
Philip L. Felgner University of California, Irvine
Peter A. Barry
Peter A. Barry Royal Marsden NHS Foundation Trust
Pierre Baldi
Pierre Baldi University of California, Irvine
Deborah Dean
Deborah Dean University of California, San Francisco
Guangming Zhong
Guangming Zhong The University of Texas Health Science Center at San Antonio
Servaas A. Morré
Servaas A. Morré Maastricht University
David M. Ojcius
David M. Ojcius University of the Pacific
Nicholas R. Thomson
Nicholas R. Thomson Wellcome Sanger Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, pursuing related degrees in nursing can open diverse career paths in healthcare. Many students begin with foundational programs like the easiest absn programs to get into, which offer accelerated Bachelor of Science in Nursing degrees. These programs are tailored for individuals with non-nursing backgrounds, easing their transition into the field.

Alternatively, if you’re coming from a different career or aiming to enter nursing from scratch, exploring online bsn programs for non nurses can provide flexibility and accessibility to pursue your goals alongside your current commitments.

For advanced specialization, many professionals seek an accelerated fnp program. This fast-tracks the path to becoming a Family Nurse Practitioner, an essential role in patient care with a strong foundation in immunological health.

Nurses looking to deepen their expertise may also consider acquiring an acute care np certification. This certification prepares practitioners for critical care roles, expanding opportunities to work with patients requiring specialized immunological interventions.

Best Scientists Citing Luis M. de la Maza

Trending Scientists

Recently Published Articles